BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7893619)

  • 1. Stability of cognitive functioning early in the course of schizophrenia.
    Nopoulos P; Flashman L; Flaum M; Arndt S; Andreasen N
    Schizophr Res; 1994 Dec; 14(1):29-37. PubMed ID: 7893619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the stability of neuropsychological functioning after acute episodes of schizophrenia: one-year followup study.
    Sweeney JA; Haas GL; Keilp JG; Long M
    Psychiatry Res; 1991 Jul; 38(1):63-76. PubMed ID: 1682967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological functioning in first-episode psychosis--evidence of specific deficits.
    Riley EM; McGovern D; Mockler D; Doku VC; OCeallaigh S; Fannon DG; Tennakoon L; Santamaria M; Soni W; Morris RG; Sharma T
    Schizophr Res; 2000 May; 43(1):47-55. PubMed ID: 10828414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in cognition in schizophrenia.
    Perlick D; Mattis S; Stastny P; Teresi J
    Schizophr Res; 1992 Oct; 8(1):69-73. PubMed ID: 1358186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia.
    Gold S; Arndt S; Nopoulos P; O'Leary DS; Andreasen NC
    Am J Psychiatry; 1999 Sep; 156(9):1342-8. PubMed ID: 10484943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten year longitudinal study of neuropsychological functioning subsequent to a first episode of schizophrenia.
    Hoff AL; Svetina C; Shields G; Stewart J; DeLisi LE
    Schizophr Res; 2005 Oct; 78(1):27-34. PubMed ID: 15964177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of long-stay schizophrenics on matched verbal and visuospatial recall tasks.
    Calev A; Edelist S; Kugelmass S; Lerer B
    Psychol Med; 1991 Aug; 21(3):655-60. PubMed ID: 1946854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive functioning and symptomatology in chronic schizophrenia.
    Nelson HE; Pantelis C; Carruthers K; Speller J; Baxendale S; Barnes TR
    Psychol Med; 1990 May; 20(2):357-65. PubMed ID: 2356261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological deficits associated with schizophrenic syndromes.
    Baxter RD; Liddle PF
    Schizophr Res; 1998 Apr; 30(3):239-49. PubMed ID: 9589518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memory impairment in schizophrenia: its extent, affiliations and neuropsychological character.
    Tamlyn D; McKenna PJ; Mortimer AM; Lund CE; Hammond S; Baddeley AD
    Psychol Med; 1992 Feb; 22(1):101-15. PubMed ID: 1349439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive deficits and its relation with psychopathology and global functioning in first episode schizophrenia.
    Hegde S; Thirthalli J; Rao SL; Raguram A; Philip M; Gangadhar BN
    Asian J Psychiatr; 2013 Dec; 6(6):537-43. PubMed ID: 24309868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive deficits in schizophrenia and affective disorders: evidence for a final common pathway disorder.
    Zihl J; Grön G; Brunnauer A
    Acta Psychiatr Scand; 1998 May; 97(5):351-7. PubMed ID: 9611085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of neuropsychological differences between paranoid and nonparanoid schizophrenia patients.
    Zalewski C; Johnson-Selfridge MT; Ohriner S; Zarrella K; Seltzer JC
    Schizophr Bull; 1998; 24(1):127-45. PubMed ID: 9502551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial working memory and problem solving in schizophrenia: the effect of symptom stabilization with atypical antipsychotic medication.
    Snyder PJ; Jackson CE; Piskulic D; Olver J; Norman T; Maruff P
    Psychiatry Res; 2008 Sep; 160(3):316-26. PubMed ID: 18579217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A neuropsychological study of early onset schizophrenia.
    Hoff AL; Harris D; Faustman WO; Beal M; DeVilliers D; Mone RD; Moses JA; Csernansky JG
    Schizophr Res; 1996 May; 20(1-2):21-8. PubMed ID: 8794490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.
    Lindenmayer JP; Khan A; Iskander A; Abad MT; Parker B
    J Clin Psychiatry; 2007 Mar; 68(3):368-79. PubMed ID: 17388705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia.
    Meltzer HY; McGurk SR
    Schizophr Bull; 1999; 25(2):233-55. PubMed ID: 10416729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The need to integrate neuropsychological and experimental schizophrenia research.
    Serper MR; Harvey PD
    Schizophr Bull; 1994; 20(1):1-11; discussion 13-21. PubMed ID: 8197408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.